ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 239,99
0,17%
Dow Jones
39 786,32
0,58%
DAX
18 869,36
0,78%
Brent Oil
82,415
-0,16%
Bitcoin
64 903,30
5,45%
Registration Strip Icon for default Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Heart Test Laboratories Inc (HSCS)

  7. Heart Test Laboratories Inc (HSCS) Actualités

HSCS Heart Test Laboratories Inc

0,077001
-0,0021 (-2,65%)
Dernière mise à jour : 18:04:15
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
Heart Test Laboratories Inc HSCS NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
-0,0021 -2,65% 0,077001 18:04:15
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
0,083 0,0735 0,088 0,0791
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
24/4/202415:00GLOBEHeartSciences Announces Grant of Fundamental Patent by the..
02/4/202422:15GLOBEHeartSciences to Present at the LD Micro Invitational XIV..
26/3/202414:00GLOBEHeartSciences Announces Podium Presentation at World..
14/3/202421:15GLOBEHeartSciences Reports Third Quarter Fiscal 2024 Financial..
12/3/202414:00GLOBEHeartSciences’ Announces Peer-Reviewed Publication..
06/3/202415:00GLOBEHeartSciences Announces Canada Patent Grant Covering..
05/3/202422:55EDGAR2Form S-1 - General form for registration of securities under..
26/2/202423:32EDGAR2Form S-8 - Securities to be offered to employees in employee..
26/2/202415:00GLOBEHeartSciences Adds Key Advisor to its Scientific Advisory..
15/2/202422:30EDGAR2Form 8-K - Current report
12/2/202415:00GLOBEHeartSciences Expands its Scientific Advisory Board
01/2/202415:00GLOBEHeartSciences Appoints New Scientific Advisory Board Member
31/1/202415:00EDGAR2Form 8-K - Current report
25/1/202414:59EDGAR2Form 8-K - Current report
18/1/202414:14EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
18/1/202414:11EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
18/1/202414:00GLOBEHeartSciences Announces Results and Adjournment of Annual..
18/1/202413:55EDGAR2Form 8-K - Current report
03/1/202422:15GLOBEHeartSciences Reminds Stockholders to Vote at the Upcoming..
14/12/202322:15GLOBEHeartSciences Reports Second Quarter Fiscal 2024 Financial..
14/12/202322:07EDGAR2Form 8-K - Current report
14/12/202322:04EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
13/12/202323:25EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
11/12/202314:30EDGAR2Form SC 13G - Statement of acquisition of beneficial..
08/12/202323:14EDGAR2Form DEF 14A - Other definitive proxy statements
07/12/202323:00EDGAR2Form D/A - Notice of Exempt Offering of Securities: [Amend]
06/12/202315:21EDGAR2Form 8-K - Current report
05/12/202314:00GLOBEHeartSciences Receives FDA Confirmation for 510(k) Clearance..
28/11/202323:26EDGAR2Form PRE 14A - Other preliminary proxy statements
27/11/202322:02EDGAR2Form SC 13G - Statement of acquisition of beneficial..
27/11/202314:30EDGAR2Form 8-K - Current report
21/11/202314:30EDGAR2Form 8-K - Current report
20/11/202314:00GLOBEHeartSciences Announces Closing of License Agreements with..
17/11/202322:51EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
17/11/202322:26EDGAR2Form 8-K - Current report
13/11/202314:45GLOBEHeartSciences’ MyoVista® wavECGTM Selected for Heart..
19/10/202315:00GLOBEHeartSciences Issues Investor Update Highlighting Recent Key..
14/10/202303:36EDGAR2Form S-1/A - General form for registration of securities..
04/10/202323:00EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
26/9/202314:00GLOBEHeartSciences Receives Two New Patent Allowances, Expanding..
25/9/202314:00GLOBEHeartSciences to Participate in the Maxim Group Virtual Tech..
22/9/202322:16EDGAR2Form 8-K - Current report
21/9/202314:00EDGAR2Form 8-K - Current report
21/9/202314:00GLOBEHeartSciences Signs Definitive Agreements with the Icahn..
18/9/202312:09EDGAR2Form S-3 - Registration statement under Securities Act of..
14/9/202322:24EDGAR2Form 8-K - Current report
14/9/202322:15GLOBEHeartSciences Reports First Quarter Fiscal 2024 Financial..
14/9/202322:06EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
12/9/202322:15GLOBEHeartSciences to Present at the Gilmartin Group Emerging..
11/9/202322:15GLOBEHeartSciences Named Electrocardiography Advancement..

Dernières Valeurs Consultées

NASDAQ
HSCS
Heart Test Laboratories
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés